Simian-virus-40 footprints in human lymphoproliferative disorders of HIV− and HIV+ patients
✍ Scribed by Fernanda Martini; Riccardo Dolcetti; Annunziata Gloghini; Laura Iaccheri; Antonino Carbone; Mauro Boiocchi; Mauro Tognon
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- French
- Weight
- 185 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Cerebrospinal fluid (CSF) and serum samples from 17 patients seropositive for the human immunodeficiency virus (HIV) were analysed for specific IgG1-4 against HIV and cytomegalovirus (CMV). Measles IgG was studied as a reference to detect blood-brain barrier (BBB) defects. All patients had IgG1 anti
## Abstract Antiphospholipid (aPL) and antiplatelet (aPlt) antibodies, found in patients with autoimmune diseases, are also detected in infectious diseases. The purpose of this study was to examine the prevalence of these antibodies in HIV patients and to evaluate an association of these antibodies
Simian virus 40 (SV40), a monkey polyomavirus, was a contaminant of early poliovirus vaccines administered to millions of individuals in the 1950s and early 1960s. SV40 causes brain tumors in laboratory animals, and SV40 DNA sequences have been variably identified in human choroid plexus tumors and
## Abstract Epstein‐Barr virus (EBV) associated non‐Hodgkin lymphoma is recognized as a complication of human immunodeficiency virus (HIV) infection. Little is known regarding the influence of highly active antiretroviral therapy (HAART) on the biology of EBV in this population. To characterize the